Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours

C Horbinski, T Berger, RJ Packer, PY Wen - Nature Reviews Neurology, 2022 - nature.com
A new edition of the WHO classification of tumours of the CNS was published in 2021.
Although the previous edition of this classification was published just 5 years earlier, in …

cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors

DW Ellison, KD Aldape, D Capper, M Fouladi… - Brain …, 2020 - Wiley Online Library
Advances in our understanding of the biological basis and molecular characteristics of
ependymal tumors since the latest iteration of the World Health Organization (WHO) …

cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

DN Louis, P Wesseling, K Aldape, DJ Brat, D Capper… - 2020 - Wiley Online Library
Abstract cIMPACT‐NOW (the Consortium to Inform Molecular and Practical Approaches to
CNS Tumor Taxonomy) was established to evaluate and make practical recommendations …

Ependymoma: evaluation and management updates

R Rudà, F Bruno, A Pellerino, R Soffietti - Current Oncology Reports, 2022 - Springer
Abstract Purpose of Review To review state of art and relevant advances in the molecular
genetics and management of ependymomas of children and adults. Recent Findings …

[图书][B] Practical radiotherapy planning

S Morris, T Roques, S Ahmad, S Loo - 2023 - taylorfrancis.com
Good and effective treatment in radiotherapy requires careful consideration of the complex
variables involved as well as critical assessment of the techniques. This new edition of an …

The biology of ependymomas and emerging novel therapies

AH Saleh, N Samuel, K Juraschka, MH Saleh… - Nature Reviews …, 2022 - nature.com
Ependymomas are rare central nervous system tumours that can arise in the brain's
supratentorial region or posterior fossa, or in the spinal cord. In 1924, Percival Bailey …

Childhood cancer: occurrence, treatment and risk of second primary malignancies

S Zahnreich, H Schmidberger - Cancers, 2021 - mdpi.com
Simple Summary Childhood cancers are mostly of unknown etiology and represent
devastating diagnoses. The clinical benefits of steadily increasing tumor control and survival …

ZFTA–RELA dictates oncogenic transcriptional programs to drive aggressive supratentorial ependymoma

A Arabzade, Y Zhao, S Varadharajan, HC Chen… - Cancer discovery, 2021 - AACR
More than 60% of supratentorial ependymomas harbor a ZFTA–RELA (ZRfus) gene fusion
(formerly C11orf95–RELA). To study the biology of ZRfus, we developed an autochthonous …

Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q

LV Baroni, L Sundaresan, A Heled, H Coltin… - Neuro …, 2021 - academic.oup.com
Abstract Background Within PF-EPN-A, 1q gain is a marker of poor prognosis, however, it is
unclear if within PF-EPN-A additional cytogenetic events exist which can refine risk …

Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy

C Cacciotti, A Fleming… - The Journal of pathology, 2020 - Wiley Online Library
Central nervous system (CNS) tumors are the most common solid tumor in pediatrics,
accounting for approximately 25% of all childhood cancers, and the second most common …